Patents by Inventor Erik Holmgren
Erik Holmgren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20100281609Abstract: The present invention relates to a cover (10) intended for a pool system (1), the cover being lightly flexible and formed as a pool-covering structure and serving as a protection, where said cover (10) is adapted to cooperate in edge-related fashion with a guide arrangement (11) or similar means, said cover (10) being oriented by support means (112) at a predetermined distance from the upper surface of a body of liquid or body of water enclosed by the pool. Said cover is integrally formed with and/or adapted to support liquid-Tillable or liquid-filled channels (14, 14a) where said channels are adapted to be included in one or more thermal energy absorbing units (6a) included in one or more suntrap apparatuses (6). A liquid in these liquid-filled channels (14), heated by solar energy, is adapted to be heat exchanged with said body of liquid or body of water (2) enclosed by the pool.Type: ApplicationFiled: September 14, 2006Publication date: November 11, 2010Inventor: Lars Erik Holmgren
-
Publication number: 20060275869Abstract: The present invention provides genes encoding novel matrix metalloproteinases termed MMP; constructs and recombinant host cells incorporating the genes; the MMP polypeptides encoded by the genes; antibodies to the MMP polypeptides; and methods of making and using all of the foregoing.Type: ApplicationFiled: July 5, 2006Publication date: December 7, 2006Inventors: Timothy Wood, Jonas Ekblom, Erik Holmgren, Mats Kihlen
-
Patent number: 7070976Abstract: The present invention provides genes encoding novel matrix metalloproteinases termed MMP; constructs and recombinant host cells incorporating the genes; the MMP polypeptides encoded by the genes; antibodies to the MMP polypeptides; and methods of making and using all of the foregoing.Type: GrantFiled: March 3, 2004Date of Patent: July 4, 2006Assignee: Pfizer Inc.Inventors: Timothy Wood, Jonas Ekblom, Erik Holmgren, Mats Kihlén
-
Publication number: 20040146499Abstract: The present invention provides genes encoding novel matrix metalloproteinases termed MMP; constructs and recombinant host cells incorporating the genes; the MMP polypeptides encoded by the genes; antibodies to the MMP polypeptides; and methods of making and using all of the foregoing.Type: ApplicationFiled: March 3, 2004Publication date: July 29, 2004Inventors: Timothy Wood, Jonas Ekblom, Erik Holmgren, Mats Kihlen
-
Patent number: 6739614Abstract: A trailer hitch for heavy vehicles has a coupling housing arranged on the traction vehicle with a rear, vertical end piece from which extends an upper, forward protruding coupling yoke piece and a lower, forward protruding coupling yoke piece, between which a tow eye on a trailer and a tow ball arranged in the tow eye are intended to be secured by means of a coupling pin running through a hole in the tow ball. A principally vertical wedge (12) is arranged between both coupling yoke pieces (3, 4) in front of the rear end piece (2) and is so designed that the wedging action increases, i.e. the force of the wedge increases, as the wedge is pressed down. An intermediate piece (14), equipped partly with an upper, forward protruding part (15) and partly a lower, forward protruding part (17), is arranged between the wedge (12) and the tow ball (6), whereby the parts are intended to abut against an upper (16) and a lower (18) part of the tow ball.Type: GrantFiled: April 2, 2003Date of Patent: May 25, 2004Inventors: Sven-Erik Holmgren, Tord Jonsson
-
Publication number: 20040093165Abstract: A system and method for generating a mask layout file to eliminate antenna effects in an integrated circuit are disclosed. The method includes analyzing a pattern in a mask layout file to identify a region including an antenna ratio less than a first design rule. A feature located in the identified region is moved based on a second design rule from a first position to a second position in the mask layout file. A grounding feature is placed in the space and automatically connected to a gate feature in the mask layout file such that the antenna ratio is increased to greater than or approximately equal to the first design rule.Type: ApplicationFiled: March 18, 2003Publication date: May 13, 2004Inventors: Lars Ohman, Tomas Bonn, Mats Carlquist, Owe Engstrom, Patrick Goede, Asa Hedfors, Erik Holmgren, Konrad F. Koehler, Andrzej M. Brzozowski, Ashley C.W. Pike, Roderick E. Hubbard
-
Patent number: 6734005Abstract: The present invention provides genes encoding novel matrix metalloproteinases termed MMP; constructs and recombinant host cells incorporating the genes; the MMP polypeptides encoded by the genes; antibodies to the MMP polypeptides; and methods of making and using all of the foregoing.Type: GrantFiled: May 22, 2001Date of Patent: May 11, 2004Assignee: Pharmacia & Upjohn CompanyInventors: Timothy Wood, Jonas Ekblom, Erik Holmgren, Mats Kihlén
-
Patent number: 6617134Abstract: Substantially pure dimers of Apolipoprotein AI-Milano (APO-AI-M/APO AI-M) were isolated from plasma and characterized. Apolipoprotein AI-M dimer can also be produced in a recombinant Escherichia coli system. Pharmaceutical compositions comprising the ApoAI-AI-M/ApoAI-M are described. Patients with atherosclerosis or cardiovascular diseases can be treated with the dimer. Medicaments containing the dimer can also be used to prevent thrombosis in different clinical circumstances, both at the arterial and at the venous level. The dimer can also act as a prodrug for the monomer.Type: GrantFiled: March 1, 1999Date of Patent: September 9, 2003Assignee: Esperion Therapeutics, Inc.Inventors: Cesare Sirtori, Guido Franceschini, Lars Abrahmsén, Erik Holmgren, Mats Lake, Björn Nilsson, Joanna Chmielewska, Peter Lind
-
Publication number: 20030160431Abstract: The present invention concerns a trailer hitch for heavy vehicles, which exhibits a coupling housing arranged on the traction vehicle comprising a rear, vertical end piece from which extend's an upper, forward protruding coupling yoke piece and a lower, forward protruding coupling yoke piece, between which a low eye on a trailer and a low ball arranged in the tow eye are intended to be secured by means of a coupling pin running through a hole in the tow ball. In accordance with the invention, the trailer hitch is characterised by the following distinctive features: A principally vertical wedge (12) that is arranged between both coupling yoke pieces (3, 4) in front of the rear end piece (2) and is so designed that the wedging action increases, i.e.Type: ApplicationFiled: April 2, 2003Publication date: August 28, 2003Inventors: Sven-Erik Holmgren, Tord Jonsson
-
Publication number: 20030032164Abstract: The present invention provides genes encoding novel matrix metalloproteinases termed MMP; constructs and recombinant host cells incorporating the genes; the MMP polypeptides encoded by the genes; antibodies to the MMP polypeptides; and methods of making and using all of the foregoing.Type: ApplicationFiled: May 22, 2001Publication date: February 13, 2003Inventors: Timothy Wood, Jonas Ekblom, Erik Holmgren, Mats Kihlen
-
Publication number: 20030032779Abstract: The present invention is directed to crystals comprising at least part of the estrogen receptor &agr; (ER&agr;) ligand binding domain, optionally bound to a ligand. The present invention is also directed to ligands that bind to ER receptors, and method of designing them. The present invention is also directed to a homology model of the ER&bgr; receptor.Type: ApplicationFiled: June 5, 2002Publication date: February 13, 2003Inventors: Lars Ohman, Tomas Bonn, Mats Carlquist, Owe Engstrom, Patrick Goede, Asa Hedfors, Erik Holmgren, Konrad F. Koehler, Andrzej M. Brzozowski, Ashley C.W. Pike, Roderick E. Hubbard
-
Patent number: 6492424Abstract: Novel glucocorticoid and thyroid receptor ligands as provided which have the general formula (I): in which R1 is an aliphatic hydrocarbon, an aromatic hydrocarbon, carboxylic acid or ester thereof, alkenyl carboxylic acid or ester thereof, hydroxy, halogen, or cyano, or a pharmaceutically acceptable salt thereof. R2 and R3 are the same or different, and are hydrogen, halogen, alkyl of 1 to 4 carbons, or cycloalkyl of 3 to 5 carbons, at least one of R2 and R3 being other than hydrogen. X is carbonyl or methylene. R4 is an aliphatic, aromatic or heteroaromatic. Y is hydroxyl, methoxy, amino, or alkyl amino. n is an integer from 0 to 4. A method for treating diseases associated with metabolism dysfunction or which are dependent on the expression of a glucocorticoid or thyroid receptor gene such as diabetes, hypercholesterolemia, or obesity using these compounds is also disclosed.Type: GrantFiled: April 9, 2001Date of Patent: December 10, 2002Assignee: Karo Bio ABInventors: Theresa Apelqvist, Patrick Goede, Erik Holmgren
-
Patent number: 5876968Abstract: Substantially pure dimers of Apolipoprotein Al-Milano (Al-M/APO Al-M) isolated and characterized from plasma are provided. Pharmaceutical compositions comprising the Apo Al-M/Apo Al-M are also provided. Apolipoprotein Al-M dimer can be produced in a recombinant Escherichia coli system or collected from plasma from Apolipoprotein Al-Milano carriers. Atherosclerosis and cardiovascular diseases can be treated with the dimer. Medicaments containing the dimer can also be used for preventing thrombosis in different clinical circumstances, both at the arterial and at the venous level. The dimer can also act as a prodrug for the monomer.Type: GrantFiled: November 4, 1993Date of Patent: March 2, 1999Assignee: Pharmacia & Upjohn AktiebolagInventors: Cesare Sirtori, Guido Franceschini, Lars Abrahmsen, Erik Holmgren, Mats Lake, Bjorn Nilsson, Joanna Chmielewska, Peter Lind
-
Patent number: 5721114Abstract: The invention relates to an expression system giving high extracellular production of apolipoprotein AI-M (Milano) using E. coli and comprises a plasmid carrying an origin of replication, an inducible promoter sequence, a DNA sequence coding for a signal peptide, a DNA sequence coding for apolipoprotein AI-M, and a transcription terminator. The invention also relates to a method of producing apolipoprotein AI-M using the expression system.Type: GrantFiled: August 25, 1995Date of Patent: February 24, 1998Assignee: Pharmacia & Upjohn AktiebolagInventors: Lars Abrahamsen, Erik Holmgren, Christina Kalderen, Mats Lake, .ANG.sa Mikaelsson, Torsten Sejlitz
-
Patent number: 5411732Abstract: A process for preparing antibodies specific for an amino acid sequence which comprises immunizing a mammal with a fused protein comprising said amino acid sequence fused to an immunogenic IgG binding protein is disclosed.Type: GrantFiled: October 1, 1993Date of Patent: May 2, 1995Assignee: Kabi Pharmacia AktiebolagInventors: Bjorn Lowenadler, Erik Holmgren, Mathias Uhlen, Bjorn Nilsson